MDMA

A study of a large, nationally representative sample of U.S. adults has revealed that those who reported lifetime use of ecstasy (i.e., using ecstasy at least once in their life) were less likely to report having difficulty dealing with strangers,...

A new experiment in Japan showed that when mice are exposed to a chronic social defeat stress condition, they develop a number of adverse health conditions. But these adverse health conditions were absent in mice that were repeatedly injected with...

MDMA-assisted therapy reduces eating disorder symptoms in adults with severe posttraumatic stress disorder (PTSD), according to a new study published in the Journal of Psychiatric Research.

The drug MDMA (3,4-methylenedioxymethamphetamine) might not produce depressive "comedowns" when used in a controlled clinical setting, according to new research published in the Journal of Psychopharmacology. The findings offers some initial evidence that declines in mood and cognition in the...

Low doses of MDMA do not appear to cause negative effects in rodent models of addiction and depression, according to new research published in Psychopharmacology. But doses higher than 3 mg/kg result in observable impairments.

New research provides evidence that MDMA-assisted psychotherapy can improve and extend lives of patients with chronic and severe posttraumatic stress disorder while also reducing healthcare costs. The findings have been published in the journal PLOS One.

MDMA-assisted psychotherapy might help improve sleep in patients suffering from post-traumatic stress disorder, according to a secondary analysis of data collected from randomized, double-blind Phase 2 trials. The new findings appear in the Journal of Traumatic Stress. "People with PTSD...

A study published in Frontiers in Psychiatry lends support for a relationship-based approach to the treatment of post-traumatic stress disorder (PTSD). The researchers tested the efficacy of Cognitive Behavioral Conjoint Therapy, a couples therapy tailored to patients with PTSD and...

Post-traumatic stress disorder (PTSD) affects roughly 7 million people in the United States alone. It is associated with a variety of comorbid conditions, including depression, anxiety, and increased risk of heart attack. Developing effective new therapies to combat it is...

New research suggests that MDMA-assisted therapy for the treatment of posttraumatic stress disorder (PTSD) is less effective among those who have recently used selective serotonin reuptake inhibitors (SSRIs), a common psychiatric medication. The findings have been published in the journal...

While the drug MDMA makes people feel closer to others, it does not appear to enhance pro-social behavior, according to a new double-blind, placebo-controlled study published in the Journal of Psychopharmacology. MDMA, the drug popularly known as ecstasy, is often...

While a number of pharmaco- and psychotherapies exist to treat post-traumatic stress disorder (PTSD), a large group of individuals, including military veterans and first responders, have demonstrated resistance to classical approaches. As a result, less traditional treatments have been explored,...

MDMA induces only minimal and comparatively weak alterations of consciousness compared with LSD, according to the first controlled study to conduct a head-to-head comparison of the drugs. The findings have been published in the journal Neuropsychopharmacology. "MDMA and LSD are...

MDMA, more commonly known as ecstasy, can safely enhance the treatment of post-traumatic stress disorder when it is used in a clinical setting alongside psychotherapy, according to new research in Psychopharmacology that analyzed the outcomes of clinical trials. "In 2004,...

New research suggests that MDMA-assisted psychotherapy for post-traumatic stress disorder is associated with several beneficial side effects. In addition to reductions in PTSD symptoms, the treatment may be associated with lasting personal benefits and enhanced quality of life, according to...